Patent US4816466A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4816466A Expired / Lapsed US ⏱️ 0.0 years remaining

Piperidine derivatives

Assignee: Takeda Pharmaceutical Co Ltd
•
Filing: 1988-04-12
•
Granted: 1989-03-28
•
Expires: 2008-04-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel Compounds of the formula: ##STR1## [wherein A is an α-amino acid residue; B is a group represented by the formula: ##STR2## (wherein R 4 is hydrogen, lower alkyl, aralkyl or amino-lower alkyl), whereby the linkage between the symbols A and B designates a peptide bond and the group R 4 is B may be linked with A; R 1 is hydrogen, lower alkyl or aralkyl; R 2 is hydrogen, lower alkyl, aralkyl or acyl; X is alkylene] and salts thereof posses, for example, inhibitory activity on angiotension converting enzyme, and are useful as an agent for diagnosis, prevention or treatment of hypertension as well as circulatory diseases such as cardiopathy and cerebral apoplexy.

Inventors

  • 👤 Hirosada Sugihara
  • 👤 Kohei Nishikawa
  • 👤 Katsumi Ito

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 18:04
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/02; C07K5/022; C07K5/0222; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 49 words
A compound of the formula ##STR173## wherein R 4' is lower alkyl; R 1 is hydrogen, lower alkyl or phenyl-lower alkyl; R 2 is hydrogen, lower alkyl, phenyl-lower alkyl, lower alkanoyl, benzoyl, phenyl-lower alkoxycarbonyl or lower alkoxycarbonyl; and X is C 1-7 alkylene; or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 49 words
A compound of the formula ##STR173## wherein R 4' is lower alkyl; R 1 is hydrogen, lower alkyl or phenyl-lower alkyl; R 2 is hydrogen, lower alkyl, phenyl-lower alkyl, lower alkanoyl, benzoyl, phenyl-lower alkoxycarbonyl or lower alkoxycarbonyl; and X is C 1-7 alkylene; or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 14 words
A compound according to claim 1, wherein R 1 is hydrogen or lower alkyl.
Claim 4
Dependent Claim 11 words
A compound according to claim 1, wherein R 1 is hydrogen.
Claim 5
Dependent Claim 11 words
A compound according to claim 1, wherein R 2 is hydrogen.
Claim 6
Dependent Claim 13 words
A compound according to claim 1, wherein X is trimethylene, tetramethylene or pentamethylene.
Claim 7
Dependent Claim 10 words
A compound according to claim 1, wherein X is tetramethylene.
Claim 8
Dependent Claim 9 words
A compound according to claim 1, which is N-[N-[(S)-1-carboxy-5-(4-piperidyl)pentyl]-L-alanyl]-N-(indan-2-yl)glycine
Claim 9
Dependent Claim 43 words
A pharmaceutical composition suitable for prevention or treatment of hypertension which comprises, as an active ingredient, an effective antihypertensive amount of a compound as claimed in claim 1 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, excipient or diluent therefor.
Claim 10
Dependent Claim 35 words
A method for prevention or treatment of hypertension in a mammal, which comprises administering to said mammal an effective antihypertensive amount of a compound as claimed in claim 1 or a pharmaceutically acceptable salt thereof.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-03-27 1992-09-26 1993-03-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-03-27 1996-09-26 1997-03-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-03-27 2000-09-26 2001-03-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag